Compounded in Thailand Manufactured in Thai FDA-licensed compounding laboratories operating under GMP standards
Nitric oxide and lipid peroxidation
MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis
Rahman Z, Kavanagh J, Champlin R, Giles R, Hanania E, Fu SQ, Zu Z, Mehra R, Holmes F, Kudelka A, Claxton D, Verschraegen C, Gajewski J, Andreeff M , Heimfeld S, Berenson R, Ellerson D, Calvert L, Dayn A, Holzmayer T, Hamer J, Bachier C, Ostrove J, Przepiorka D, Burtners B, Cote R, Bast R, Hortobagyi G, Deisseroth A
Apr 26 2019;11(5)doi:10.3390/nu11050962 Boniol M, Franchi M, Bota M, et al
Run the initial retatrutide starting dose of 1 mg weekly for the first four weeks